Osthole attenuates ovalbumin‑induced lung inflammation via the inhibition of IL‑33/ST2 signaling in asthmatic mice

Yang,Qingqing; Kong,Lingwen; Huang,Weiling; Mohammadtursun,Nabijan; Li,Xiumin; Wang,Guifang; Wang,Lixin

doi:10.3892/ijmm.2020.4682

Osthole attenuates ovalbumin‑induced lung inflammation via the inhibition of IL‑33/ST2 signaling in asthmatic mice

Authors:
- Qingqing Yang
- Lingwen Kong
- Weiling Huang
- Nabijan Mohammadtursun
- Xiumin Li
- Guifang Wang
- Lixin Wang
View Affiliations

Affiliations: Department of Respiratory Medicine, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200071, P.R. China, Department of Integrative Medicine, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China, Department of Pediatrics, Jaffe Food Allergy Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA, Department of Respiratory Medicine, Huashan Hospital, Fudan University, Shanghai 200040, P.R. China, Department of Integrated Traditional Chinese and Western Medicine, Shanghai Pulmonary Hospital, Tongji University, Shanghai 200433, P.R. China
Published online on: July 22, 2020 https://doi.org/10.3892/ijmm.2020.4682
Pages: 1389-1398
Copyright: © Yang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Asthma is a common chronic inflammatory airway disease. Recent studies have reported that interleukin (IL)‑33 is a potential link between the airway epithelium and Th2‑type inflammatory responses, which are closely related to the progression of asthma. The IL‑33 receptor, ST2, is highly expressed in group 2 innate lymphoid cells (ILC2s), Th2 cells, mast cells, eosinophils and natural killer (NK) cells. Cnidii Fructus is a Chinese herb with a long history of use in the treatment of asthma in China. Osthole is one of the major components of Cnidii Fructus. The present study examined the anti‑asthmatic effects of osthole in mice and aimed to elucidate the underlying mechanisms involving the IL‑33/ST2 pathway. BALB/c mice were sensitized and challenged with ovalbumin and then treated with an intraperitoneal injection of osthole (25 and 50 mg/kg). Subsequently, the airway hyper‑responsiveness (AHR) and inflammation of the lungs were evaluated. The amounts of IL‑4, IL‑5, IL‑13, interferon (IFN)‑γ and IL‑33 in the bronchoalveolar lavage fluid (BALF) were measured by Luminex assay and their mRNA levels in the lungs were measured by reverse transcription‑quantitative PCR. The histopathology of the lungs was performed with H&E, PAS and Masson's staining. The expression of ST2 in the lungs was evaluated by immunohistochemistry. The data demonstrated that osthole markedly reduced AHR and decreased the number of eosinophils and lymphocytes in BALF. It was also observed that osthole significantly inhibited the release of Th2‑type cytokines (IL‑4, IL‑5 and IL‑13) and upregulated the IFN‑γ level in BALF. Moreover, osthole significantly attenuated the IL‑33 and ST2 expression in the lungs of asthmatic mice. On the whole, osthole attenuated ovalbumin‑induced lung inflammation through the inhibition of IL‑33/ST2 signaling in an asthmatic mouse model. These results suggest that osthole is a promising target for the development of an asthma medication.

View Figures

View References

1	Bostantzoglou C, Delimpoura V, Samitas K, Zervas E, Kanniess F and Gaga M: Clinical asthma phenotypes in the real world: Opportunities and challenges. Breathe (Sheff). 11:186–193. 2015. View Article : Google Scholar
2	Galli SJ, Tsai M and Pilponsky AM: The development of allergic inflammation. Nature. 454:445–454. 2008. View Article : Google Scholar : PubMed/NCBI
3	Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, Ohta K, O'Byrne P, Pedersen SE, et al: Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J. 31:143–178. 2008. View Article : Google Scholar : PubMed/NCBI
4	Oliphant CJ, Barlow JL and McKenzie AN: Insights into the initiation of type 2 immune responses. Immunology. 134:378–385. 2011. View Article : Google Scholar : PubMed/NCBI
5	Fahy JV: Type 2 inflammation in asthma-present in most, absent in many. Nat Rev Immunol. 15:57–65. 2015. View Article : Google Scholar :
6	Martinez FD and Vercelli D: Asthma. Lancet. 382:1360–1372. 2013. View Article : Google Scholar : PubMed/NCBI
7	Hwang YH, Paik MJ and Yee ST: Diisononyl phthalate induces asthma via modulation of Th1/Th2 equilibrium. Toxicol Lett. 272:49–59. 2017. View Article : Google Scholar : PubMed/NCBI
8	Platts-Mills TA: The allergy epidemics: 1870-2010. J Allergy Clin Immunol. 136:3–13. 2015. View Article : Google Scholar : PubMed/NCBI
9	Locksley RM: Asthma and allergic inflammation. Cell. 140:777–783. 2010. View Article : Google Scholar : PubMed/NCBI
10	Smith DE: IL-33: A tissue derived cytokine pathway involved in allergic inflammation and asthma. Clin Exp Allergy. 40:200–208. 2010. View Article : Google Scholar
11	Ravanetti L, Dijkhuis A, Sabogal Pineros YS, Bal SM, Dierdorp BS, Dekker T, Logiantara A, Adcock IM, Rao NL, Boon L, et al: An early innate response underlies severe influenza-induced exacerbations of asthma in a novel steroid-insensitive and anti-IL-5-responsive mouse model. Allergy. 72:737–753. 2017. View Article : Google Scholar
12	Saluja R, Ketelaar ME, Hawro T, Church MK, Maurer M and Nawijn MC: The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders. Mol Immunol. 63:80–85. 2015. View Article : Google Scholar
13	Kaur D, Gomez E, Doe C, Berair R, Woodman L, Saunders R, Hollins F, Rose FR, Amrani Y, May R, et al: IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: Airway smooth muscle crosstalk. Allergy. 70:556–567. 2015. View Article : Google Scholar : PubMed/NCBI
14	Ahmed A and Koma MK: Interleukin-33 triggers B1 cell expansion and its release of monocyte/macrophage chemoattractants and growth factors. Scand J Immunol. 82:118–124. 2015. View Article : Google Scholar : PubMed/NCBI
15	Iijima K, Kobayashi T, Hara K, Kephart GM, Ziegler SF, McKenzie AN and Kita H: IL-33 and thymic stromal lymphopoietin mediate immune pathology in response to chronic airborne allergen exposure. J Immunol. 193:1549–1559. 2014. View Article : Google Scholar : PubMed/NCBI
16	Gordon ED, Simpson LJ, Rios CL, Ringel L, Lachowicz-Scroggins ME, Peters MC, Wesolowska-Andersen A, Gonzalez JR, MacLeod HJ, Christian LS, et al Alternative splicing of interleukin-33 and type 2 inflammation in asthma. Proc Natl Acad Sci USA. 113:8765–8770. 2016. View Article : Google Scholar : PubMed/NCBI
17	Hristova M, Habibovic A, Veith C, Janssen-Heininger YMW, Dixon AE, Geiszt M and van der Vliet A: Airway epithelial dual oxidase 1 mediates allergen-induced IL-33 secretion and activation of type 2 immune responses. J Allergy Clin Immunol. 137:1545–1556. 2016. View Article : Google Scholar
18	Préfontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, Martin JG and Hamid Q: Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol. 125:752–754. 2010. View Article : Google Scholar : PubMed/NCBI
19	Guo Z, Wu J, Zhao J, Liu F, Chen Y, Bi L, Liu S and Dong L: IL-33 promotes airway remodeling and is a marker of asthma disease severity. J Asthma. 51:863–869. 2014. View Article : Google Scholar : PubMed/NCBI
20	Savenije OE, Mahachie John JM, Granell R, Kerkhof M, Dijk FN, de Jongste JC, Smit HA, Brunekreef B, Postma DS, Van Steen K, et al: Association of IL33-IL-1 receptor-like 1 (IL1RL1) pathway polymorphisms with wheezing phenotypes and asthma in childhood. J Allergy Clin Immunol. 134:170–177. 2014. View Article : Google Scholar : PubMed/NCBI
21	Keenan CR, Salem S, Fietz ER, Gualano RC and Stewart AG: Glucocorticoid-resistant asthma and novel anti-inflammatory drugs. Drug Discov Today. 17:1031–1038. 2012. View Article : Google Scholar : PubMed/NCBI
22	He XF, Pan WD, Yao YL and Zhang HM: Recent highlights of Chinese herbs in treatment of allergic disease: Acting via mitogen-activated protein kinase signal pathway. Chin J Integr Med. 23:570–573. 2017. View Article : Google Scholar
23	Shao YY, Zhou YM, Hu M, Li JZ, Chen CJ, Wang YJ, Shi XY, Wang WJ and Zhang TT: The anti-allergic rhinitis effect of traditional Chinese medicine of shenqi by regulating mast cell degranulation and Th1/Th2 cytokine balance. Molecules. 22:E5042017. View Article : Google Scholar : PubMed/NCBI
24	Li YQ, Wang JY, Qian ZQ, Li YL, Li WN, Gao Y and Yang DL: Osthole inhibits intimal hyperplasia by regulating the NF-κB and TGF-β1/Smad2 signalling pathways in the rat carotid artery after balloon injury. Eur J Pharmacol. 811:232–239. 2017. View Article : Google Scholar : PubMed/NCBI
25	Gao Z, Wen Q, Xia Y, Yang J, Gao P, Zhang N, Li H and Zou S: Osthole augments therapeutic efficiency of neural stem cells-based therapy in experimental autoimmune encephalomyelitis. J Pharmacol Sci. 124:54–65. 2014. View Article : Google Scholar : PubMed/NCBI
26	Kordulewska NK, Kostyra E, Cieślińska A, Fiedorowicz E and Jarmołowska B: Cytokine production by PBMC and serum from allergic and non-allergic subjects following in vitro histamine stimulation to test fexofenadine and osthole anti-allergic proper-ties. Eur J Pharmacol. 791:763–772. 2016. View Article : Google Scholar : PubMed/NCBI
27	Chen X, Pi R, Zou Y, Liu M, Ma X, Jiang Y, Mao X and Hu X: Attenuation of experimental autoimmune encephalomyelitis in C57 BL/6 mice by osthole, a natural coumarin. Eur J Pharmacol. 629:40–46. 2010. View Article : Google Scholar
28	Hua KF, Yang SM, Kao TY, Chang JM, Chen HL, Tsai YJ, Chen A, Yang SS, Chao LK and Ka SM: Osthole mitigates progressive IgA nephropathy by inhibiting reactive oxygen species generation and NF-κB/NLRP3 pathway. PLoS One. 8:e777942013. View Article : Google Scholar
29	Matsuda H, Tomohiro N, Ido Y and Kubo M: Anti-allergic effects of cnidii monnieri fructus (dried fruits of Cnidium monnieri) and its major component, osthol. Biol Pharm Bull. 25:809–812. 2002. View Article : Google Scholar : PubMed/NCBI
30	Chiu PR, Lee WT, Chu YT, Lee MS, Jong YJ and Hung CH: Effect of the Chinese herb extract osthol on IL-4 induced eotaxin expression in BEAS-2B cells. Pediatr Neonatol. 49:135–140. 2008. View Article : Google Scholar : PubMed/NCBI
31	Sun J, Wu J, Xu C, Luo Q, Li B and Dong J: Paeoniflorin attenuates allergic inflammation in asthmatic mice. Int Immunopharmacol. 24:88–94. 2015. View Article : Google Scholar
32	Glaab T, Daser A, Braun A, Neuhaus-Steinmetz U, Fabel H, Alarie Y and Renz H: Tidal midexpiratory flow as a measure of airway hyperresponsiveness in allergic mice. Am J Physiol Lung Cell Mol Physiol. 280:L565–L573. 2001. View Article : Google Scholar : PubMed/NCBI
33	Milstrey A, Wieskoetter B, Hinze D, Grueneweller N, Stange R, Pap T, Raschke M and Garcia P: Dose-dependent effect of parathyroid hormone on fracture healing and bone formation in mice. J Surg Res. 220:327–335. 2017. View Article : Google Scholar : PubMed/NCBI
34	Qiao Y, Song L, Zhu C, Wang Q, Guo T, Yan Y and LI Q: Dataset on preparation of the phosphorylated counterparts of a momordica charantia protein for studying antifungal activities against susceptible dose-dependent C. albicans to antimycotics. Data Brief. 15:370–375. 2017. View Article : Google Scholar : PubMed/NCBI
35	Arancio AL, Cole KD, Dominguez AR, Cohenour ER, Kadie J, Maloney WC, Cilliers C, Schuh SM, Bisphenol A and Bisphenol AF: Di-N-Butyl phthalate, and 17β-estradiol have shared and unique dose-dependent effects on early embryo cleavage divisions and development in Xenopus laevis. Reprod Toxicol. 84:65–74. 2019. View Article : Google Scholar
36	Schmittgen TD and Livak KJ: Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
37	Virchow JC, Backer V, Kuna P, Prieto L, Nolte H, Villesen HH, Ljørring C, Riis B and de Blay F: Efficacy of a house dust mite sublingual allergen immunotherapy tablet in adults with allergic asthma: A randomized clinical trial. JAMA. 315:1715–1725. 2016. View Article : Google Scholar : PubMed/NCBI
38	Qian J, Ma X, Xun Y and Pan L: Protective effect of forsythiaside A on OVA-induced asthma in mice. Eur J Pharmacol. 812:250–255. 2017. View Article : Google Scholar : PubMed/NCBI
39	Wijerathne CUB, Seo CS, Song JW, Park HS, Moon OS, Won YS, Kwon HJ and Son HY: Isoimperatorin attenuates airway inflammation and mucus hypersecretion in an ovalbumin-induced murine model of asthma. Int Immunopharmacol. 49:67–76. 2017. View Article : Google Scholar : PubMed/NCBI
40	Grotenboer NS, Ketelaar ME, Koppelman GH and Nawijn MC: Decoding asthma: Translating genetic variation in IL33 and IL1RL1 into disease pathophysiology. J Allergy Clin Immunol. 131:856–865. 2013. View Article : Google Scholar : PubMed/NCBI
41	Pichery M, Mirey E, Mercier P, Lefrancais E, Dujardin A, Ortega N and Girard JP: Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: In situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol. 188:3488–3495. 2012. View Article : Google Scholar : PubMed/NCBI
42	Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, et al: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associ-ated cytokines. Immunity. 23:479–490. 2005. View Article : Google Scholar : PubMed/NCBI
43	Liew FY, Pitman NI and McInnes IB: Disease-associated functions of IL-33: The new kid in the IL-1 family. Nat Rev Immunol. 10:103–110. 2010. View Article : Google Scholar : PubMed/NCBI
44	Griesenauer B and Paczesny S: The ST2/IL-33 axis in immune cells during inflammatory diseases. Front Immunol. 8:4752017. View Article : Google Scholar : PubMed/NCBI
45	Bønnelykke K, Sleiman P, Nielsen K, Kreiner-Møller E, Mercader JM, Belgrave D, den Dekker HT, Husby A, Sevelsted A, Faura-Tellez G, et al: A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet. 46:51–55. 2014. View Article : Google Scholar
46	Wan Y, Shrine NR, Soler Artigas M, Wain LV, Blakey JD, Moffatt MF, Bush A, Chung KF, Cookson WO, Strachan DP, et al: Genome-wide association study to identify genetic determinants of severe asthma. Thorax. 67:762–768. 2012. View Article : Google Scholar : PubMed/NCBI
47	Morita H, Arae K, Unno H, Miyauchi K, Toyama S, Nambu A, Oboki K, Ohno T, Motomura K, Matsuda A, et al: An inter-leukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T cell numbers. Immunity. 43:175–186. 2015. View Article : Google Scholar : PubMed/NCBI
48	Martin NT and Martin MU: Interleukin 33 is a guardian of barriers and a local alarmin. Nat Immunol. 17:122–131. 2016. View Article : Google Scholar : PubMed/NCBI
49	Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S and Kastelein RA: IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol. 179:2551–2555. 2007. View Article : Google Scholar : PubMed/NCBI
50	Liew FY, Girard JP and Turnquist HR: Interleukin-33 in health and disease. Nat Rev Immunol. 16:676–689. 2016. View Article : Google Scholar : PubMed/NCBI
51	Drake LY and Kita H: IL-33: Biological properties, functions, and roles in airway disease. Immunol Rev. 278:173–184. 2017. View Article : Google Scholar : PubMed/NCBI
52	Jackson DJ, Makrinioti H, Rana BM, Shamji BWH, Trujillo-Torralbo MB, Footitt J, Del-Rosario J, Telcian AG, Nikonova A, Zhu J, et al: IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med. 190:1373–1382. 2014. View Article : Google Scholar : PubMed/NCBI
53	Rank MA, Kobayashi T, Kozaki H, Bartemes KR, Squillace DL and Kita H: IL-33-activated dendritic cells induce an atypical TH2-type responses. J Allergy Clin Immunol. 123:1047–1054. 2009. View Article : Google Scholar : PubMed/NCBI
54	Kurowska-Stolarska M, Stolarski B, Kewin P, Murphy G, Corrigan CJ, Ying S, Pitman N, Mirchandani A, Rana B, van Rooijen N, et al: IL-33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation. J Immunol. 183:6469–6477. 2009. View Article : Google Scholar : PubMed/NCBI
55	Millien VO, Lu W, Shaw J, Yuan X, Mak G, Roberts L, Song LZ, Knight JM, Creighton CJ, Luong A, et al: Cleavage of brinogen by proteinases elicits allergic responses through Toll-like receptor 4. Science. 341:792–796. 2013. View Article : Google Scholar : PubMed/NCBI
56	Yanagawa Y, Suzuki M, Matsumoto M and Togashi H: Prostaglandin E(2) enhances IL-33 production by dendritic cells. Immunol Lett. 141:55–60. 2011. View Article : Google Scholar : PubMed/NCBI